U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis (Q33535382)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis |
scientific article |
Statements
1 reference
U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis (English)
1 reference
Meyerhoff A
1 reference
1 January 1999
1 reference
1 reference
28
1 reference
42-8; discussion 49-51
1 reference
Identifiers
1 reference
1 reference